首页|期刊导航|中华医学杂志(英文版)|In-hospital outcomes of anemic patients with acute coronary syndrome receiving ticagrelor versus clopidogrel:Results of the Chinese Cardiovascular Care Improvement(CCC)-Acute Coronary Syndrome Project
In-hospital outcomes of anemic patients with acute coronary syndrome receiving ticagrelor versus clopidogrel:Results of the Chinese Cardiovascular Care Improvement(CCC)-Acute Coronary Syndrome Project
Zhiqiang Zhang Yasong Wang Jun Wang Xiaofan Cao Miaohan Qiu Xiaoxiang Tian Yaling Han Xiaozeng Wang
中华医学杂志(英文版)2024,Vol.137Issue(20):2489-2491,3.
中华医学杂志(英文版)2024,Vol.137Issue(20):2489-2491,3.DOI:10.1097/CM9.0000000000003279
In-hospital outcomes of anemic patients with acute coronary syndrome receiving ticagrelor versus clopidogrel:Results of the Chinese Cardiovascular Care Improvement(CCC)-Acute Coronary Syndrome Project
In-hospital outcomes of anemic patients with acute coronary syndrome receiving ticagrelor versus clopidogrel:Results of the Chinese Cardiovascular Care Improvement(CCC)-Acute Coronary Syndrome Project
摘要
引用本文复制引用
Zhiqiang Zhang,Yasong Wang,Jun Wang,Xiaofan Cao,Miaohan Qiu,Xiaoxiang Tian,Yaling Han,Xiaozeng Wang..In-hospital outcomes of anemic patients with acute coronary syndrome receiving ticagrelor versus clopidogrel:Results of the Chinese Cardiovascular Care Improvement(CCC)-Acute Coronary Syndrome Project[J].中华医学杂志(英文版),2024,137(20):2489-2491,3.基金项目
This study was supported by the China National Key R&D Project(contract No.2022YFC2503500) (contract No.2022YFC2503500)
The CCC-ACS project is a program of the AHA and the CSC.The AHA received funding from Pfizer through an independent grant for learning and change and Astra-Zeneca as a quality improvement initiative. ()